Skip to content

The impact of referral letters on patient outcomes: A randomised control trial with video vignettes in Australian general practice.

A Modified Randomised Control Trial to identify whether any difference exists in the ability of specialists to triage patients based on referral letters created by GPs using their existing clinical systems compared with the Referral Writer software.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000760976
Acronym
RW study
Enrollment
88
Registered
2011-07-20
Start date
2011-08-01
Completion date
2012-08-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The data in this study offer evidence for the value of the referral writer, a computerised, interactive pro forma in improving the utility of referral letters when patients are referred for a specialist opinionby general practitioners. Comprehensive referral letters, based on the evidence for the predictive value of various elements of the history and examination have a significant value in ensuring that the patient is seen by the right specialist at the right time.

Interventions

This study aims to assess the effectiveness of a computerised referral system, the Referral Writer (RW), to improve the quality of GP referral letters and the ability of specialists to prioritise patient appointments and make a diagnosis. Phase 1: 10 Actor-patient consultations based on a pre-determined script will be video recorded and posted onto a secure password protected website. 'Patients" will present with symptoms of one of six cancers. The 88 Participants (GPs) will asked to view the 10

This study aims to assess the effectiveness of a computerised referral system, the Referral Writer (RW), to improve the quality of GP referral letters and the ability of specialists to prioritise patient appointments and make a diagnosis. Phase 1: 10 Actor-patient consultations based on a pre-determined script will be video recorded and posted onto a secure password protected website. 'Patients" will present with symptoms of one of six cancers. The 88 Participants (GPs) will asked to view the 10 video consultations, decide whether to refer the ‘patient’ and produce referral letters to specialists. This is envisaged to take a period of one month. Phase 2: Stratified randomisation of the 88 Participants (GPs) will occur and they will be split them into two groups of 44. These groups will be asked to view, over one month, 14 new different video consultations of actor patients presenting with symptoms of one of the six cancers. One group of GP participants, will decide whether to refer the ‘patient’ and produce referral letters to specialists using their standard system of generating letters. The second group of GP participants decide whether to refer the ‘patient’ and produce referral letters to specialists using the RW software. The ability of specialists to triage patients using referral letters produced by standard systems will be compared with triage from referral letters written using the RW software. It is envisaged that phase 2 will take one month. This randomised control trial hopes to provide evidence needed to support the integration of RW into existing clinical systems to enhance the referral process and improve outcomes for patients.

Sponsors

WA Cancer and Palliative Care Network
Lead SponsorOther Collaborative groups

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Participants will be general practitioners (GPs) registered with the appropariate state authority and working in community based practices across Australia. Actors to take part in the simulated consultations will be recruited from an existing pool of actors the research team has used previously.

Exclusion criteria

GP participants will be excluded from the study if they are unable to provide informed consent.

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 4, 2026